Before Brands, Inc., a Menlo Park, CA-based consumer products company which leverages science to create proprietary nutritional products, raised $35m in Series B financing.
The round was led by Gurnet Point Capital. In conjunction with the funding, Christopher Viehbacher, the Managing Partner of Gurnet Point Capital and former CEO of Sanofi S.A., and Greg Horn, the CEO of Specialty Nutrition Group, Inc. and former CEO of both GNC Holdings, Inc. and Garden of Life, will join Before Brands’ Board.
The company intends to use the funds to launch its first line of proprietary dietary supplements (including the novel Early Adaptive Training™ protein blend with Vitamin D) later in 2017 and launch medical education initiatives on daily protein training strategies that include foods like peanut and egg as a consistent part of the diet beginning before age one.
Led by Dr. Ashley Dombkowski, co-founder and CEO, Before Brands is advancing products founded on evidence in support of nutritional strategies that include potentially allergenic foods as a regular part of a diet. These products are designed to be incorporated into the diet of infants beginning around 6 months of age as part of solid food introduction. They based on insights and intellectual property developed by Dr. Kari Nadeau, pediatrician and Director of the Sean N. Parker Center for Allergy and Asthma Research at Stanford University, and licensed to the company by Stanford University on an exclusive, global basis.